Tenet Healthcare Corporation (THC)
Cash ratio
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash and cash equivalents | US$ in thousands | 3,019,000 | 4,094,000 | 2,880,000 | 2,481,000 | 1,228,000 | 1,054,000 | 934,000 | 766,000 | 858,000 | 1,208,000 | 1,351,000 | 1,405,000 | 2,364,000 | 2,292,000 | 2,194,000 | 2,141,000 | 2,446,000 | 3,300,000 | 3,514,000 | 613,000 |
Short-term investments | US$ in thousands | — | — | — | — | — | — | — | — | -1,518,000 | — | — | — | -1,439,000 | 2,564,000 | 2,525,000 | 2,577,000 | -1,507,000 | 2,445 | — | — |
Total current liabilities | US$ in thousands | 4,310,000 | 5,538,000 | 5,493,000 | 5,416,000 | 4,760,000 | 4,432,000 | 4,152,000 | 4,219,000 | 4,476,000 | 4,276,000 | 4,368,000 | 4,668,000 | 5,109,000 | 5,379,000 | 5,071,000 | 4,930,000 | 4,847,000 | 5,843,000 | 5,585,000 | 4,095,000 |
Cash ratio | 0.70 | 0.74 | 0.52 | 0.46 | 0.26 | 0.24 | 0.22 | 0.18 | -0.15 | 0.28 | 0.31 | 0.30 | 0.18 | 0.90 | 0.93 | 0.96 | 0.19 | 0.57 | 0.63 | 0.15 |
December 31, 2024 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($3,019,000K
+ $—K)
÷ $4,310,000K
= 0.70
The cash ratio of Tenet Healthcare Corporation has fluctuated over the years, ranging from a low of -0.15 to a high of 0.96. However, a positive trend is observed in recent quarters with an increase in the cash ratio from 0.18 in March 2022 to 0.70 in December 2024. This indicates that the company has improved its ability to cover its short-term liabilities with cash and cash equivalents. Overall, the cash ratio trend reflects varying levels of liquidity and financial health of the company during the period under review.
Peer comparison
Dec 31, 2024